Copyright
©The Author(s) 2024.
World J Gastroenterol. Mar 14, 2024; 30(10): 1368-1376
Published online Mar 14, 2024. doi: 10.3748/wjg.v30.i10.1368
Published online Mar 14, 2024. doi: 10.3748/wjg.v30.i10.1368
Table 4 Stage distribution according to diagnostic routes at each hospital, n (%)
| Tumor stage | KU | WMC | ||||
| Follow-up group (n = 271) | Symptomatic group (n = 480) | Cancer screening group (n = 128) | Follow-up group (n = 444) | Symptomatic group (n = 584) | Cancer screening group (n = 176) | |
| Stage 0 | 62 (22.9) | 22 (4.6) | 20 (15.6) | 154 (34.7) | 70 (12.0) | 61 (34.7) |
| Stage I | 89 (32.8) | 82 (17.1) | 50 (39.1) | 105 (23.7) | 80 (13.7) | 50 (28.4) |
| Stage II | 39 (14.4) | 113 (23.5) | 14 (10.9) | 67 (15.1) | 127 (21.8) | 25 (14.2) |
| Stage III | 43 (15.9) | 120 (25.0) | 23 (18.0) | 66 (14.9) | 177 (30.3) | 31 (17.6) |
| Stage IV | 38 (14.0) | 143 (29.8) | 21 (16.4) | 52 (11.7) | 130 (22.3) | 9 (5.1) |
| Early-stage | 151 (55.7) | 104 (21.7) | 70 (54.7) | 259 (58.3) | 150 (25.7) | 111 (63.1) |
- Citation: Agatsuma N, Utsumi T, Nishikawa Y, Horimatsu T, Seta T, Yamashita Y, Tanaka Y, Inoue T, Nakanishi Y, Shimizu T, Ohno M, Fukushima A, Nakayama T, Seno H. Stage at diagnosis of colorectal cancer through diagnostic route: Who should be screened? World J Gastroenterol 2024; 30(10): 1368-1376
- URL: https://www.wjgnet.com/1007-9327/full/v30/i10/1368.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i10.1368